Latest Articles

Publication Date
All News Scientific
Sensei Biotherapeutics Acquires Faeth Therapeutics, Raises $200M to Advance Multi-Node Cancer Therapy for Endometrial and Breast Cancer - Femtech Insider

Sensei Biotherapeutics Acquires Faeth Therapeutics, Raises $200M to Advance Multi-Node Cancer Therapy for Endometrial and Breast Cancer Femtech Insider

Published: Feb. 18, 2026, 3:28 p.m.
Read Full Article
Sensei Biotherapeutics Acquires Faeth Therapeutics in $200M Deal, Advancing Multi-Node Cancer Therapy for Endometrial and Breast Cancer - Femtech Insider

Sensei Biotherapeutics Acquires Faeth Therapeutics in $200M Deal, Advancing Multi-Node Cancer Therapy for Endometrial and Breast Cancer Femtech Insider

Published: Feb. 18, 2026, 3:28 p.m.
Read Full Article
Epigenetic Landscape of Female Infertility: An Integrated Bioinformatics Perspective on DNA Methylation, MicroRNAs, and Gene Regulatory Networks Across PCOS, Endometriosis, and Diminished Ovarian Reserve.

Female infertility diseases such as polycystic ovary syndrome (PCOS), endometriosis, diminished ovarian reserve (DOR), and recurrent implantation failure (RIF) have different clinical phenotypes. However, they might be epigenetically convergent, and …

Published: Feb. 12, 2026, midnight
Read Full Article
DNA methylation PCOS bioinformatics endometriosis epigenetics female infertility microRNA ovarian reserve
AstraZeneca Pharma India Secures CDSCO Nod for Expanded Use of Durvalumab in Cancer Treatment - NewsGram

AstraZeneca Pharma India Secures CDSCO Nod for Expanded Use of Durvalumab in Cancer Treatment NewsGram

Published: Feb. 11, 2026, 3:33 a.m.
Read Full Article
AstraZeneca gets regulator’s nod to market cancer drug Imfinzi for additional indication - thehindu.com

AstraZeneca gets regulator’s nod to market cancer drug Imfinzi for additional indication thehindu.com

Published: Feb. 10, 2026, 9:33 a.m.
Read Full Article
AstraZeneca gets regulator’s nod to market cancer drug Imfinzi for additional indication - The Hindu

AstraZeneca gets regulator’s nod to market cancer drug Imfinzi for additional indication The Hindu

Published: Feb. 10, 2026, 9:33 a.m.
Read Full Article
AstraZeneca gets Indian regulator's nod to market cancer drug Imfinzi - Business Standard

AstraZeneca gets Indian regulator's nod to market cancer drug Imfinzi Business Standard

Published: Feb. 10, 2026, 9:10 a.m.
Read Full Article
AstraZeneca gets CDSCO nod to market cancer drug Imfinzi for additional indication - The Economic Times

AstraZeneca gets CDSCO nod to market cancer drug Imfinzi for additional indication The Economic Times

Published: Feb. 10, 2026, 8:44 a.m.
Read Full Article
AstraZeneca Pharma shares gain as it receives CDSCO nod for import of endometrial cancer treatment drug - CNBC TV18

AstraZeneca Pharma shares gain as it receives CDSCO nod for import of endometrial cancer treatment drug CNBC TV18

Published: Feb. 10, 2026, 6:11 a.m.
Read Full Article
AstraZeneca Pharma India Gets CDSCO Nod for Cancer Drug Imfinzi - Whalesbook

AstraZeneca Pharma India Gets CDSCO Nod for Cancer Drug Imfinzi Whalesbook

Published: Feb. 10, 2026, 5:34 a.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!